Wall Street Analysts Think Nuvation Bio (NUVB) Could Surge 32.05%: Read This Before Placing a Bet

Nuvation Bio Inc. (NUVB) closed the last trading session at $8.58, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.33 indicates a 32.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $2.78. While the lowest estimate of $8.00 indicates a 6.8% decline from the current price level, the most optimistic analyst ex ...